BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/3/2024 8:27:51 AM | Browse: 227 | Download: 442
 |
Received |
|
2023-12-05 03:52 |
 |
Peer-Review Started |
|
2023-12-05 03:52 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-01-27 06:25 |
 |
Revised |
|
2024-02-22 14:37 |
 |
Second Decision |
|
2024-03-13 02:47 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-03-13 06:25 |
 |
Articles in Press |
|
2024-03-13 06:25 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-03-28 01:21 |
 |
Publish the Manuscript Online |
|
2024-04-03 07:21 |
ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Oncology |
Manuscript Type |
Review |
Article Title |
Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Samantha Sharma, Naresh Singh, Anita Ahmed Turk, Isabella Wan, Akshay Guttikonda, Julia Lily Dong, Xinna Zhang and Mateusz Opyrchal |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
IU Simon Comprehensive Cancer Center grant |
5P30CA082709-24 |
|
Corresponding Author |
Samantha Sharma, PhD, Assistant Professor, Department of Medical and Molecular Genetics, Indiana University School of Medicine, 980 W Walnut St, R3.C260, Indianapolis, IN 46202, United States. samshar@iu.edu |
Key Words |
Colorectal cancer; Immune checkpoint inhibitors; Clinical trials; Immunotherapy; Microsatellite instability; Microsatellite stability; DNA mismatch repair |
Core Tip |
Colorectal cancer (CRC) often eludes early detection, limiting the efficacy of existing chemotherapy and targeted therapies. This article delves into the realm of immune checkpoint inhibitors in CRC, dissecting their mechanisms and outcomes through a comprehensive review of clinical trials. It sheds light on the underlying rationale, challenges faced, and potential strategies to improve prognosis and trial success in this critical domain. Notably, while microsatellite instability-high CRC exhibits heightened responsiveness to checkpoint inhibitors, the article underscores potential breakthroughs in treating microsatellite stable CRC-the predominant cases-providing insights into bettering prognosis and trial outcomes in CRC treatment. |
Publish Date |
2024-04-03 07:21 |
Citation |
Sharma S, Singh N, Turk AA, Wan I, Guttikonda A, Dong JL, Zhang X, Opyrchal M. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions. World J Gastroenterol 2024; 30(13): 1815-1835 |
URL |
https://www.wjgnet.com/1007-9327/full/v30/i13/1815.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v30.i13.1815 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345